Table 2 Classification of chemotherapy response within the breast

From: A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

Final grading of breast response

 

pCR

188 (23%)

MRD

85 (10%)

Chemotherapy response present

228 (28%)

No response

17 (2%)

No comment re-chemotherapy response

307 (37%)

All non-pCR cases

Formal comment re-chemotherapy response

287 (45%)

No comment re-chemotherapy response

350 (55%)